Revista Urología Colombiana / Colombian Urology Journal

LinksSchließen

Referenz

Fizazi K, Scher HI, Miller K. , et al.
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.

Lancet Oncol 2014;
15 (10) 1147-1156

Bibliographische Angaben herunterladen

Aufrufen in: